首页> 美国卫生研究院文献>BioMedicine >P-coumaric acid regulates exon 12 splicing of the ATP7B gene by modulating hnRNP A1 protein expressions
【2h】

P-coumaric acid regulates exon 12 splicing of the ATP7B gene by modulating hnRNP A1 protein expressions

机译:对香豆酸通过调节hnRNP A1蛋白表达来调节ATP7B基因的外显子12剪接

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background: Wilson’s disease (WD) is a genetic disorder involving the metabolism of copper. WD patients exhibit a wide range of disease phenotypes, including Kayser-Fleischer rings in the cornea, predominant progressive hepatic disease, neurological diseases, and/or psychiatric illnesses, among others. Patients with exon12 mutations of the ATP7B gene have progressive hepatic disease. An ATP7B gene that lacks exon12 retains 80% of its copper transport activities, suggesting that alternative splicing of ATP7B gene may provide alternative therapeutic ways for patients with inherited sequence variants and mutations of this gene. Purpose: We aimed to search for possible Chinese herbs and related compounds for modulating ATP7B premRNA splicing.Methods: We used an ATP7B exon11-12-13 mini-gene vector as a model and screened 18 Chinese herbal extracts and four compounds from Schizonepeta to determine their effects on ATP7B pre-mRNA splicing in vitro.Results: We found that Schizonepeta demonstrated the greatest potential for alternative splicing activity. Specifically, we found that p-coumaric acid from this herb enhanced ATP7B exon12 exclusion through the down-regulation of heterogeneous ribonucleoprotein (hnRNP) A1 protein expressions.Conclusion: These results suggest that there are herbs or herb-related compounds that could modify the alternative splicing of the ATP7B gene via a mechanism that regulates pre-mRNA splicing.
机译:背景:威尔逊氏病(WD)是一种涉及铜代谢的遗传疾病。 WD患者表现出广泛的疾病表型,包括角膜中的Kayser-Fleischer环,主要的进行性肝病,神经系统疾病和/或精神病等。 ATP7B基因的exon12突变的患者患有进行性肝病。缺少exon12的ATP7B基因保留了其80%的铜转运活性,这表明ATP7B基因的可变剪接可能为具有遗传序列变异和该基因突变的患者提供替代治疗方法。目的:我们旨在寻找可能的中草药及其相关化合物来调节ATP7B premRNA剪接方法:我们以ATP7B exon11-12-13微型基因载体为模型,筛选了18种中草药提取物和荆芥中的四种化合物结果:Schizonepeta表现出最大的选择性剪接活性潜力。具体来说,我们发现该草药中的对香豆酸通过下调异源核糖核蛋白(hnRNP)A1蛋白的表达增强了ATP7B exon12的排除作用。通过调节前mRNA剪接的机制剪接ATP7B基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号